nach oben

Lasers in Medical Science

Erschienen in:

01.08.2016 | Original Article

A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway

verfasst von: Wenjing Mao, Yan Sun, Huankang Zhang, Luhong Cao, Jiajia Wang, Peijie He

Erschienen in: Lasers in Medical Science | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Photodynamic therapy (PDT) has been developed as a promising treatment modality for laryngeal cancer. 9-Hydroxypheophorbide α (9-HPbD), a novel chlorophyll-derived photosensitizer, has a longer absorption wavelength, which increases the penetration of light to malignant tissues. Carboplatin (CBDCA), a second-generation platinum derivative, also has gained more popularity for the treatment of laryngeal cancer. Our previous studies have elucidated that 9-HPbD-PDT could inhibit the migration and invasion of HEp-2 cells. The objective of this study is to investigate the change of migration and invasion of HEp-2 cells induced by a combined modality of CBDCA and 9-HPbD-PDT in vitro. A wound healing assay, cell migration assay and Matrigel invasion assay were used to evaluate the cellular migration and invasion. Reactive oxygen species (ROS) and Western blots for epithelial-mesenchymal transition (EMT) markers (E-cadherin, N-cadherin and vimentin), MMPs (MMP-2 and MMP-9) and MEK/ERK signalling pathway were performed to investigate the possible mechanisms that may be involved. We observed that CBDCA and 9-HPbD-PDT administration synergistically inhibited the migration and invasion of HEp-2 cells. Moreover, the combined modality cooperatively repressed the EMT process and down-regulated expressions of MMP-2 and MMP-9 via ROS-mediated inhibition of phosphorylation in the MEK/ERK signalling pathway. Our results suggested that the combination of CBDCA and 9-HPbD-PDT might be a promising therapeutic strategy for laryngeal cancer metastasis.

Chu EA, Kim YJ (2008) Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 41:673–695CrossRefPubMed

Tian Y, Leung W, Yue K, Mak N (2006) Cell death induced by MPPa-PDT in prostate carcinoma in vitro and in vivo. Biochem Biophys Res Commun 348:413–420CrossRefPubMed

Nowak-Sliwinska P, Karocki A, Elas M, Pawlak A, Stochel G, Urbanska K (2006) Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells. Biochem Biophys Res Commun 349:549–555CrossRefPubMed

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61:250–281CrossRefPubMedPubMedCentral

Ahn JC, Chung PS (2012) The activity of G-ROS and the predominant role of Type II reaction in the photodynamic therapy using 9-hydroxypheophorbide-alpha for HeLa cell lines. Gen Physiol Biophys 31:343–350CrossRefPubMed

Zhang H, Shen B, Swinarska JT, Li W, Xiao K, He P (2014) 9-Hydroxypheophorbide alpha-mediated photodynamic therapy induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in Hep-2 cells via ROS-mediated suppression of the ERK pathway. Photodiagnosis Photodyn Ther 11:55–62CrossRefPubMed

Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776:86–107PubMed

Biel MA (2010) Photodynamic therapy of head and neck cancers. Methods Mol Biol 635:281–293CrossRefPubMed

Verma S, Watt GM, Mai Z, Hasan T (2007) Strategies for enhanced photodynamic therapy effects. Photochem Photobiol 83:996–1005CrossRefPubMed

10.

Rajeswaran A, Trojan A, Burnand B, Giannelli M (2008) Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer 59:1–11CrossRefPubMed

11.

Ohguri T, Kunugita N, Yahara K, Imada H, Uemura H, Shinya N, Youjirou G, Takashi C, Okazaki R, Ootsuyama A, Korogi Y (2015) Efficacy of hyperbaric oxygen therapy combined with mild hyperthermia for improving the anti-tumour effects of carboplatin. Int J Hyperthermia 31:643–648CrossRefPubMed

12.

Hwang H, Biswas R, Chung PS, Ahn JC (2013) Modulation of EGFR and ROS induced cytochrome c release by combination of photodynamic therapy and carboplatin in human cultured head and neck cancer cells and tumor xenograft in nude mice. J Photochem Photobiol B 128:70–77CrossRefPubMed

13.

Biswas R, Mondal A, Ahn JC (2015) Deregulation of EGFR/PI3K and activation of PTEN by photodynamic therapy combined with carboplatin in human anaplastic thyroid cancer cells and xenograft tumors in nude mice. J Photochem Photobiol B 148:118–127CrossRefPubMed

14.

He P, Ahn JC, Shin JI, Hwang HJ, Kang JW, Lee SJ, Chung PS (2009) Enhanced apoptotic effect of combined modality of 9-hydroxypheophorbide alpha-mediated photodynamic therapy and carboplatin on AMC-HN-3 human head and neck cancer cells. Oncol Rep 21:329–334PubMed

15.

Chung PS, He P, Shin JI, Hwang HJ, Lee SJ, Ahn JC (2009) Photodynamic therapy with 9-hydroxypheophorbide alpha on AMC-HN-3 human head and neck cancer cells: induction of apoptosis via photoactivation of mitochondria and endoplasmic reticulum. Cancer Biol Ther 8:1343–1351CrossRefPubMed

16.

Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2:329–333CrossRefPubMed

17.

Ahn JC, Biswas R, Moon JH, Chung PS (2014) Cellular uptake of 9-hydroxypheophorbide-alpha and its photoactivation to induce ER stress-related apoptosis in human cervical cancer cells. Lasers Med Sci 29:289–299CrossRefPubMed

18.

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674CrossRefPubMed

19.

Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871–890CrossRefPubMed

20.

Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939CrossRefPubMed

21.

Naber HP, Drabsch Y, Snaar-Jagalska BE, Ten DP, van Laar T (2013) Snail and Slug, key regulators of TGF-beta-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun 435:58–63CrossRefPubMed

22.

Willis AL, Sabeh F, Li XY, Weiss SJ (2013) Extracellular matrix determinants and the regulation of cancer cell invasion stratagems. J Microsc 251:250–260CrossRefPubMed

23.

Zhao W, Lu M, Zhang Q (2015) Chloride intracellular channel 1 regulates migration and invasion in gastric cancer by triggering the ROS-mediated p38 MAPK signaling pathway. Mol Med Rep 12:8041–8047PubMedPubMedCentral

24.

Baquero P, Jiménez-Mora E, Santos A, Lasa M, Chiloeches A (2015) TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways. Mol Carcinog. doi:10.1002/mc.22415 PubMed

25.

Zhang YQ, Wei XL, Liang YK, Chen WL, Zhang F, Bai JW, Qiu SQ, Du CW, Huang WH, Zhang GJ (2015) Over-expressed Twist associates with markers of epithelial mesenchymal transition and predicts poor prognosis in breast cancers via ERK and Akt activation. PLoS One 10:e135851

26.

Gu J, Han T, Ma RH, Zhu YL, Jia YN, Du JJ, Chen Y, Jiang XJ, Xie XD, Guo X (2014) SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer. Int J Oncol 44:481–490PubMed

27.

Shang C, Guo Y, Fu S, Fu W, Sun K (2010) SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2. Med Sci Monit 16:R168–R173

28.

Liu WH, Chang LS (2010) Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway. J Cell Physiol 224:775–785CrossRefPubMed

29.

Kim TH, Kim YK, Woo JS (2012) The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca(2)(+)/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells. Neurochem Res 37:2667–2677CrossRefPubMed

30.

Arai K, Lee SR, Lo EH (2003) Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 43:254–264CrossRefPubMed

31.

Mendes O, Kim HT, Lungu G, Stoica G (2007) MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 24:341–351CrossRefPubMed

32.

Liu WH, Chen YJ, Chien JH, Chang LS (2014) Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells. J Cell Physiol 229:588–598CrossRefPubMed

33.

Zhao L, Geng H, Liang ZF, Zhang ZQ, Zhang T, Yu DX, Zhong CY (2015) Benzidine induces epithelial-mesenchymal transition in human uroepithelial cells through ERK1/2 pathway. Biochem Biophys Res Commun 459:643–649CrossRefPubMed

34.

Qiao B, Johnson NW, Gao J (2010) Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. Int J Oncol 37:663–668PubMed

35.

Shaili E (2014) Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments. Sci Prog 97:20–40CrossRefPubMed

Titel: A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway
verfasst von: Wenjing Mao
Yan Sun
Huankang Zhang
Luhong Cao
Jiajia Wang
Peijie He
Publikationsdatum: 01.08.2016
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 8/2016
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-016-2040-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

A combined modality of carboplatin and photodynamic therapy suppresses epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in HEp-2 human laryngeal cancer cells via ROS-mediated inhibition of MEK/ERK signalling pathway

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Reporting quality of randomized controlled trial abstracts published in leading laser medicine journals: an assessment using the CONSORT for abstracts guidelines

Improving the outcome of fractional CO2 laser resurfacing using a probiotic skin cream: Preliminary clinical evaluation

Wound healing efficacy of a 660-nm diode laser in a rat incisional wound model

Laser fluorescence detection of subgingival calculus using the DIAGNOdent Classic versus periodontal probing

Laser biostimulation of wound healing: bioimpedance measurements support histology

Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study